The Influence of Regional Adiposity on Atherogenic Risk Factors in Men and Women with Type 2 Diabetes

To determine firstly whether body fat distribution could predict the presence of atherogenic risk factors better than overall adiposity in Type 2 diabetes, and secondly whether sex differences in these risk factors could be explained by sex differences in fat distribution, waist‐to‐hip girth ratio (WHR), serum lipids, lipoproteins, apolipoproteins, plasma lipolytic activity, and blood pressure were assessed in 47 patients with Type 2 diabetes, 21 women matched for age, body mass index (BMI) and blood glucose control with 26 men. The men had higher WHR (0.95 (range 0.83–1.07) vs 0.82 (0.74–0.94), p < 0.001), lower HDL‐cholesterol (1.03 ± 0.05 vs 1.38 ± 0.06 mmol l−1, p < 0.001) and apolipoprotein A1 (1.40 ± 0.06 vs 1.76 ± 0.06 gl−1, p < 0.001) concentrations, and higher hepatic lipase activities (16.2 (6.4–38.0) vs 8.6 (2.3–23.1) mmol h−1 l−1, p < 0.01). In both men and women, BMI and WHR were positively related to serum triglyceride, insulin and C‐peptide concentrations. In women, HDL‐cholesterol was negatively related to BMI (r = −0.45, p < 0.05) but only possibly related to WHR (r = −0.33, NS). In men, by contrast, WHR was related negatively to HDL‐cholesterol (r = −0.60, p < 0.005), HDL2‐cholesterol (r = −0.43, p < 0.05), and apolipoprotein A1 (r = −0.70, p < 0.001) and positively to hepatic lipase activity (r = 0.65, p < 0.001), whereas the same relationships with BMI were not significant. Neither WHR nor BMI was significantly related to systolic or diastolic blood pressure in men or women. When 10 men and 10 women were matched for WHR, the sex difference in HDL‐cholesterol, HDL2‐cholesterol and hepatic lipase activity lost statistical significance but apolipoprotein A1 and HDL3‐cholesterol remained significantly lower in men. WHR is thus a better predictor than BMI of several atherogenic risk factors in men (but not women) with Type 2 diabetes. The observed sex differences in factors relating to HDL metabolism can be only partially explained by differences in regional adiposity.

[1]  I. Godsland,et al.  Sex, plasma lipoproteins, and atherosclerosis: prevailing assumptions and outstanding questions. , 1987, American heart journal.

[2]  P. Belfrage,et al.  Simple liquid-liquid partition system for isolation of labeled oleic acid from mixtures with glycerides. , 1969, Journal of lipid research.

[3]  A. Kissebah,et al.  Relation of body fat distribution to metabolic complications of obesity. , 1982, The Journal of clinical endocrinology and metabolism.

[4]  D. Steiner,et al.  The metabolism of proinsulin and insulin by the liver. , 1972, The Journal of clinical investigation.

[5]  W L Haskell,et al.  Regional adiposity patterns in relation to lipids, lipoprotein cholesterol, and lipoprotein subfraction mass in men. , 1989, The Journal of clinical endocrinology and metabolism.

[6]  J. Vague,et al.  The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. , 1956, The American journal of clinical nutrition.

[7]  L. Sjöström,et al.  Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution. , 1983, The Journal of clinical investigation.

[8]  A. Kissebah,et al.  Relation of Body Fat Distribution to Metabolic Complications of Obesity , 1982 .

[9]  M. Staten,et al.  The ratio of waist-to-hip circumference, plasma insulin level, and glucose intolerance as independent predictors of the HDL2 cholesterol level in older adults. , 1990, The New England journal of medicine.

[10]  W. Brown,et al.  A new method for the measurement of lipoprotein lipase in postheparin plasma using sodium dodecyl sulfate for the inactivation of hepatic triglyceride lipase. , 1979, Journal of lipid research.

[11]  H. Hauner,et al.  Fat distribution, endocrine and metabolic profile in obese women with and without hirsutism. , 1988, Metabolism: clinical and experimental.

[12]  E. A. Sims,et al.  Evidence for an increased risk for hypertension with centrally located body fat and the effect of race and sex on this risk. , 1984, American journal of epidemiology.

[13]  S. Haffner,et al.  Do Upper-Body and Centralized Adiposity Measure Different Aspects of Regional Body-Fat Distribution? Relationship to Non-Insulin-Dependent Diabetes Mellitus, Lipids, and Lipoproteins , 1987, Diabetes.

[14]  L. Gaal,et al.  Relationship of Body Fat Distribution Pattern to Atherogenic Risk Factors in NIDDM: Preliminary Results , 1988, Diabetes Care.

[15]  C. Bouchard,et al.  Role of hepatic-triglyceride lipase activity in the association between intra-abdominal fat and plasma HDL cholesterol in obese women. , 1989, Arteriosclerosis.

[16]  R. Hoffmann,et al.  Adiposity, fat distribution, and cardiovascular risk. , 1989, Annals of internal medicine.

[17]  R. Mueller,et al.  Splanchnic insulin metabolism in obesity. Influence of body fat distribution. , 1986, The Journal of clinical investigation.

[18]  W. Richmond,et al.  The response of hepatic lipase to acute hyperinsulinaewa , 1990 .

[19]  D. Owens,et al.  INSULIN DEFICIENCY IN NON-INSULIN-DEPENDENT DIABETES , 1989, The Lancet.

[20]  S. Haffner,et al.  Hyperinsulinemia, upper body adiposity, and cardiovascular risk factors in non-diabetics. , 1988, Metabolism: clinical and experimental.

[21]  E. Vartiainen,et al.  Postheparin plasma lipoprotein and hepatic lipase are determinants of hypo- and hyperalphalipoproteinemia. , 1989, Journal of lipid research.

[22]  D. Johnston,et al.  The Role of Insulin Insensitivity and Hepatic Lipase in the Dyslipidaemia of Type 2 Diabetes , 1991, Diabetic medicine : a journal of the British Diabetic Association.

[23]  J. Seidell,et al.  Measures of fat distribution as determinants of serum lipids in healthy volunteers consuming a uniform standardized diet , 1988, European journal of clinical investigation.

[24]  M. Jensen,et al.  Influence of body fat distribution on free fatty acid metabolism in obesity. , 1989, The Journal of clinical investigation.

[25]  D. Freedman,et al.  Body fat distribution and male/female differences in lipids and lipoproteins. , 1990, Circulation.

[26]  S. Hampton,et al.  Insulin and C-Peptide Levels After Oral and Intravenous Glucose: Contribution of Enteroinsular Axis to Insulin Secretion , 1986, Diabetes.

[27]  T. Cole,et al.  Obesity: new insight into the anthropometric classification of fat distribution shown by computed tomography. , 1985, British medical journal.

[28]  K. Shirai,et al.  Hydrolysis of human plasma high density lipoprotein 2- phospholipids and triglycerides by hepatic lipase. , 1981, Biochemical and biophysical research communications.

[29]  A. Siegelaub,et al.  Difference in Diabetic and Nondiabetic Fat Distribution Patterns by Skinfold Measurements , 1969, Diabetes.

[30]  S. Hampton.  The C-peptide of proinsulin : its diagnostic use and a possible physiological role , 1983 .

[31]  A. Katz,et al.  Metabolism of proinsulin, insulin, and C-peptide in the rat. , 1973, The Journal of clinical investigation.

[32]  R G Hoffmann,et al.  Relationship of body fat topography to insulin sensitivity and metabolic profiles in premenopausal women. , 1984, Metabolism: clinical and experimental.

[33]  G. R. Warnick,et al.  Postheparin Plasma Triglyceride Lipases , 1985, Arteriosclerosis.

[34]  A. Rimm,et al.  The association of girth measurements with disease in 32,856 women. , 1984, American journal of epidemiology.